Literature DB >> 6327547

Steroid metabolism in an androblastoma (Sertoli-Leydig cell tumor): a histopathological and biochemical study.

H E Stegner, B P Lisboa.   

Abstract

Steroidogenesis in a histologically and ultrastructurally clearly defined Sertoli-Leydig cell tumor ( androblastoma ) was studied by incubation of tumor slices with tritiated and unlabeled pregnenolone. Metabolites were isolated by thin-layer and gel-column chromatography and identified by gas chromatography associated with a radioactivity detector and/or by gas chromatography-mass spectrometry. Steroids were detected by mass chromatography as the trimethylsilyl- or tert-butyldimethylsilyl ethers. The following steroids were found: progesterone, 20 alpha-dihydroprogesterone, 17 alpha-hydroxypregnenolone, 5-pregnene-3 beta,20 alpha-diol, 4-androstene-3,17-dione, dehydroepiandrosterone, testosterone, androsterone, and etiocholanolone. The two latter C19-steroids were found to be the principal metabolites. Neither estradiol-17 beta nor estrone were detected. There was evidence from ultramicroscopic studies that in addition to typical Leydig cells, neoplastic stromal and sex cord cells are involved in androgen metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327547     DOI: 10.1097/00004347-198404000-00009

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

Review 1.  Ovarian tumors with functioning manifestations.

Authors:  Fattaneh A Tavassoli
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

2.  An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli-Leydig cell tumour.

Authors:  Zaina S Inam; Abdul Hussain Azizi; Soemiwati W Holland
Journal:  BMJ Case Rep       Date:  2018-03-01

3.  Cystic Sertoli-Leydig Cell Tumour in a Postmenopausal Woman with Absent Virilising Symptoms: A Diagnostic Challenge.

Authors:  Vidya Monappa; Saritha M Reddy; Ranjini Kudva; Muralidhar V Pai
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 4.  [Endocrine-active tumors of the ovary].

Authors:  H-E Stegner; Th Löning
Journal:  Pathologe       Date:  2003-06-19       Impact factor: 1.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.